Retinal vascular diseases: management.
Foster
C S
CS
Regan
C D
CD
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy; D003692:Delayed-Action Preparations; D005128:Eye Diseases / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy; D009184:Mydriatics / Q000008:administration & dosage; D010488:Polyarteritis Nodosa / Q000150:complications / Q000188:drug therapy; D012164:Retinal Diseases / Q000188:drug therapy / Q000209:etiology; D012171:Retinal Vessels; D012507:Sarcoidosis / Q000150:complications / Q000188:drug therapy; D013315:Stress, Psychological / Q000628:therapy; D013997:Time Factors; D014605:Uveitis / Q000188:drug therapy / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D009184:Mydriatics